Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 50% ± 18% | |
peripheral blood | 20 studies | 67% ± 17% | |
brain | 19 studies | 41% ± 19% | |
intestine | 11 studies | 43% ± 14% | |
eye | 11 studies | 33% ± 13% | |
kidney | 9 studies | 44% ± 16% | |
liver | 6 studies | 40% ± 14% | |
pancreas | 5 studies | 55% ± 22% | |
bone marrow | 5 studies | 56% ± 30% | |
heart | 5 studies | 23% ± 6% | |
uterus | 5 studies | 63% ± 15% | |
adipose | 5 studies | 32% ± 16% | |
prostate | 5 studies | 43% ± 18% | |
lymph node | 5 studies | 68% ± 5% | |
placenta | 4 studies | 62% ± 25% | |
esophagus | 4 studies | 48% ± 24% | |
breast | 4 studies | 54% ± 7% | |
adrenal gland | 3 studies | 53% ± 19% | |
skin | 3 studies | 51% ± 20% | |
thymus | 3 studies | 57% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 43567.82 | 1445 / 1445 | 100% | 531.61 | 183 / 183 |
ovary | 100% | 21285.23 | 180 / 180 | 100% | 349.97 | 430 / 430 |
uterus | 100% | 25340.22 | 170 / 170 | 100% | 418.47 | 459 / 459 |
breast | 100% | 26348.29 | 459 / 459 | 100% | 484.38 | 1117 / 1118 |
lung | 100% | 25668.31 | 577 / 578 | 100% | 454.28 | 1155 / 1155 |
bladder | 100% | 24886.38 | 21 / 21 | 100% | 453.29 | 502 / 504 |
prostate | 100% | 22069.54 | 245 / 245 | 100% | 252.01 | 500 / 502 |
skin | 100% | 39067.44 | 1809 / 1809 | 100% | 327.13 | 470 / 472 |
intestine | 100% | 27996.25 | 966 / 966 | 99% | 400.20 | 524 / 527 |
stomach | 100% | 19143.43 | 358 / 359 | 100% | 391.34 | 285 / 286 |
brain | 99% | 33883.59 | 2627 / 2642 | 100% | 200.53 | 704 / 705 |
thymus | 100% | 21874.85 | 653 / 653 | 99% | 242.90 | 598 / 605 |
kidney | 100% | 18900.55 | 89 / 89 | 98% | 198.61 | 881 / 901 |
adrenal gland | 100% | 22675.64 | 258 / 258 | 97% | 200.59 | 222 / 230 |
pancreas | 90% | 9281.98 | 295 / 328 | 98% | 343.34 | 175 / 178 |
liver | 75% | 6507.41 | 169 / 226 | 74% | 118.66 | 301 / 406 |
adipose | 100% | 29770.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 28254.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 241.93 | 29 / 29 |
spleen | 100% | 22499.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 417.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 331.25 | 1 / 1 |
peripheral blood | 99% | 34304.67 | 922 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 231.67 | 75 / 80 |
heart | 92% | 11460.27 | 791 / 861 | 0% | 0 | 0 / 0 |
muscle | 76% | 6321.39 | 608 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0001525 | Biological process | angiogenesis |
GO_0008039 | Biological process | synaptic target recognition |
GO_0030324 | Biological process | lung development |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0007165 | Biological process | signal transduction |
GO_0051683 | Biological process | establishment of Golgi localization |
GO_0090128 | Biological process | regulation of synapse maturation |
GO_0090168 | Biological process | Golgi reassembly |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0035148 | Biological process | tube formation |
GO_0006605 | Biological process | protein targeting |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0003016 | Biological process | respiratory system process |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_0008104 | Biological process | protein localization |
GO_0006468 | Biological process | protein phosphorylation |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0031647 | Biological process | regulation of protein stability |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0098686 | Cellular component | hippocampal mossy fiber to CA3 synapse |
GO_0005925 | Cellular component | focal adhesion |
GO_0072562 | Cellular component | blood microparticle |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042470 | Cellular component | melanosome |
GO_0031982 | Cellular component | vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0003723 | Molecular function | RNA binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0050815 | Molecular function | phosphoserine residue binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YWHAZ |
Protein name | 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) 14-3-3 protein zeta/delta |
Synonyms | HEL-S-3 HEL4 HEL-S-93 |
Description | FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways . Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif . Binding generally results in the modulation of the activity of the binding partner . Promotes cytosolic retention and inactivation of TFEB transcription factor by binding to phosphorylated TFEB . Induces ARHGEF7 activity on RAC1 as well as lamellipodia and membrane ruffle formation . In neurons, regulates spine maturation through the modulation of ARHGEF7 activity (By similarity). . |
Accessions | E7EVZ2 ENST00000418997.1 E7EX29 P63104 D0PNI1 ENST00000522542.5 [P63104-2] ENST00000395953.6 [P63104-1] ENST00000523848.5 B0AZS6 E5RIR4 ENST00000395956.7 [P63104-1] B7Z2E6 ENST00000523131.1 ENST00000395957.6 [P63104-1] ENST00000395951.7 [P63104-1] ENST00000437293.5 ENST00000521328.5 E9PD24 ENST00000521309.5 E5RGE1 ENST00000419477.6 [P63104-1] ENST00000523938.1 ENST00000395948.6 ENST00000521607.5 ENST00000353245.7 [P63104-1] ENST00000522819.5 H0YB80 ENST00000457309.2 [P63104-1] E7ESK7 ENST00000395958.6 [P63104-1] |